Aflac Japan Sales Surge 25% as Company Returns $1.3 Billion to Shareholders (AFL Q1 2026 Earnings Call)
Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.
Aflac Incorporated delivered solid first-quarter results characterized by significant new product sales growth in Japan and steady premium momentum in the United States. This underlying operational stability supported the company's robust capital return program and facilitated a strategic expansion into the third-party reinsurance market in Japan.
Japan Sales Surge 25.5% Amid Stable Underlying Margins
Aflac Japan achieved a remarkable 25.5% year-over-year increase in first-quarter sales, driven by the successful launch of its latest medical product, Onsen Tallett, and the Miraito cancer insurance product. Despite this strong new business generation, net earned premiums in yen terms declined 3.8%, with underlying earned premiums down a more modest 1.3%. The segment demonstrated excellent profitability, as the total benefit ratio improved by 290 basis points year-over-year to 62.9%, aided by highly favorable trends in cancer and hospitalization claims. Consequently, Japan's pretax margin expanded by 320 basis points to a robust 35%.
U.S. Operations Deliver Steady Premium Growth and Solid Margins
In the United States, Aflac generated a 2.9% year-over-year increase in sales while maintaining a strong premium persistency rate of 79.3%. This stable retention helped drive a 3.5% increase in net earned premiums for the quarter. The U.S. total benefit ratio decreased by 50 basis points year-over-year to 47.2%, reflecting favorable incurred claims within the individual voluntary benefits and group disability segments. Although the expense ratio ticked up 70 basis points to 38.3% due to higher commission and amortization costs, the segment maintained solid profitability with a 20.4% pretax margin.
Capital Returns Reach $1.3 Billion as Reinsurance Strategy Advances
Aflac demonstrated its significant financial flexibility by returning $1.3 billion to shareholders during the first quarter, comprising $1 billion in share repurchases and $315 million in cash dividends. At the enterprise level, adjusted earnings per diluted share stood at $1.75. The company also announced a strategic milestone, with Aflac Re Bermuda assuming a block of whole life annuities from Japan Post Insurance. Senior Executive Vice President and CFO Max Broden noted that while this specific transaction is currently immaterial to the financials, it marks a key step in expanding Aflac's reinsurance capabilities in the Japanese market.
Management Expresses Confidence in Approaching Flat Premium Growth in Japan
During the question-and-answer session, analysts focused on the trajectory of Aflac Japan's earned premiums and the company's broader capital deployment strategies. CFO Max Broden explained that achieving flat earned premium growth requires approximately 90 billion yen in annual sales to offset regular lapsation. When pressed on the 2026 outlook, Chairman and CEO Dan Amos projected that full-year Japan sales should approach 80 billion yen, a solid increase over the prior year. Additionally, management reaffirmed that while the new external reinsurance strategy will consume some capital, it will not disrupt the company's established cadence of returning capital to shareholders.